These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12802936)

  • 1. Early second leukaemia in a patient with successfully treated acute promyelocytic leukaemia.
    Drake M; Humphreys MW; Alexander HD; Morris TC
    Leuk Lymphoma; 2003 May; 44(5):895-6. PubMed ID: 12802936
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL).
    Garcia-Manero G; Kantarjian HM; Kornblau S; Estey E
    Leukemia; 2002 Sep; 16(9):1888. PubMed ID: 12200720
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.
    Batzios C; Hayes LA; He SZ; Quach H; McQuilten ZK; Wall M; Campbell LJ
    Am J Hematol; 2009 Nov; 84(11):715-9. PubMed ID: 19806661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of myelodysplasia/acute myeloid leukemia 'on therapy' in two patients with acute promyelocytic leukemia.
    Chelghoum Y; Plesa A; Ducastelle S; Elhamri M; Thomas X
    Indian J Cancer; 2016; 53(1):59-60. PubMed ID: 27146742
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy-related MDS and AML in acute promyelocytic leukemia.
    Andersen MK; Pedersen-Bjergaard J
    Blood; 2002 Sep; 100(5):1928-9; author reply 1929. PubMed ID: 12211197
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical presentation of therapy-related acute promyelocytic leukaemia with marrow fibrosis.
    Mohamed M; Iland HJ; Sharma S; Supple SG
    Pathology; 2016 Apr; 48(3):286-8. PubMed ID: 27020510
    [No Abstract]   [Full Text] [Related]  

  • 7. [Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
    Lengfelder E; Simon M; Haase D; Hild F; Hehlmann R
    Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1143-50. PubMed ID: 8076501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
    Dalal BI; Bruyere H; Barnett MJ
    Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
    [No Abstract]   [Full Text] [Related]  

  • 9. A therapy-related myelodysplastic syndrome with unusual features in a patient treated for acute promyelocytic leukemia.
    Pecci A; Invernizzi R
    Haematologica; 2001 Jan; 86(1):102-3. PubMed ID: 11146580
    [No Abstract]   [Full Text] [Related]  

  • 10. High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders.
    Bowcock SJ; Rassam SM; Lim Z; Ward SM; Ryali MM; Mufti GJ
    Br J Haematol; 2006 Jul; 134(2):242-3. PubMed ID: 16846486
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia.
    Zompi S; Viguié F
    Leuk Lymphoma; 2002 Feb; 43(2):275-80. PubMed ID: 11999558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary acute promyelocytic leukemia: an increasingly common entity.
    Jantunen E; Heinonen K; Mahlamäki E; Penttilä K; Kuittinen T; Lehtonen P; Pyörälä M; Hänninen A; Nousiainen T
    Leuk Lymphoma; 2007 Jan; 48(1):190-1. PubMed ID: 17325866
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy-related myelodysplastic syndrome with monosomy 5 and 7 following successful therapy for acute promyelocytic leukemia with anthracyclines.
    Athanasiadou A; Saloum R; Zorbas I; Tsompanakou A; Batsis I; Fassas A; Anagnostopoulos A
    Leuk Lymphoma; 2002 Dec; 43(12):2409-11. PubMed ID: 12613533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
    Lobe I; Rigal-Huguet F; Vekhoff A; Desablens B; Bordessoule D; Mounier C; Ferrant A; Sanz M; Fey M; Chomienne C; Chevret S; Degos L; Fenaux P;
    Leukemia; 2003 Aug; 17(8):1600-4. PubMed ID: 12886249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraploidy with double t(15;17)(q22;q21) in acute promyelocytic leukaemia.
    Mohamed M; Dun K
    Pathology; 2013 Feb; 45(2):203-5. PubMed ID: 23250036
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
    Bao L; Lu X; Lai Y; Zhang X; Zhu H; Liu Y; Qin Y; Huang XJ
    Leuk Res; 2009 Jul; 33(7):e64-8. PubMed ID: 19297021
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
    Iland HJ; Collins M; Bradstock K; Supple SG; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell LJ; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF;
    Lancet Haematol; 2015 Sep; 2(9):e357-66. PubMed ID: 26685769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
    Parajuli R; Altman J; Kuzel T; Perdekamp M; Tallman M
    Am J Hematol; 2010 Oct; 85(10):829. PubMed ID: 20721888
    [No Abstract]   [Full Text] [Related]  

  • 19. Does the concurrent use of anthracycline and granulocyte colony-stimulating factor influence the risk of secondary leukaemia in breast cancer women?
    Di Cosimo S; Ferretti G; Papaldo P; Carlini P; Fabi A; Ruggeri EM; Alimonti A; Nardoni C; Cognetti F
    Ann Oncol; 2005 Jul; 16(7):1209-10. PubMed ID: 15857847
    [No Abstract]   [Full Text] [Related]  

  • 20. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
    Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
    Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.